Skip to main content
Log in

TLR4 Knockout Attenuates BDL-induced Liver Cholestatic Injury through Amino Acid and Choline Metabolic Pathways

  • Published:
Current Medical Science Aims and scope Submit manuscript

Summary

The exact mechanism by which knockout of Toll-like receptor 4 (TLR4) attenuates the liver injury remains unclear. The present study aimed to examine the role of TLR4 in the pathogenesis of bile duct ligation (BDL)-induced liver cholestatic injury and the underlying mechanism. Wild type (WT) mice and TLR4 knockout (TLR4-KO) mice were used for the establishment of the BDL model. Metabolomics were applied to analyze the changes of small molecular metabolites in the serum and liver of the two groups. The serum biochemical indexes and the HE staining results of liver tissue showed that liver damage was significantly reduced in TLR4-KO mice after BDL when compared with that in WT mice. The metabolite analysis results showed that TLR4 KO could maintain the metabolisms of amino acids- and choline-related metabolites. After BDL, the amino acids- and choline-related metabolites, especially choline and 3-hydroxybutyrate, were significantly increased in WT mice (both in serum and liver), but these metabolites in the liver of TLR4-KO mice after BLD were not significant different from those before BLD. In conclusion, TLR4 KO could attenuate BDL-induced liver cholestatic injury through regulating amino acid and choline metabolic pathways.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Oya S, Yokoyama Y, Kokuryo T, et al. Inhibition of Toll-like receptor 4 suppresses liver injury induced by biliary obstruction and subsequent intraportal lipopolysaccharide injection. Am J Physiol Gastrointest Liver Physiol, 2014,306(3):G244–G252

    Article  CAS  Google Scholar 

  2. Ueno K, Ajiki T, Watanabe H, et al. Changes in extrathymic T cells in the liver and intestinal intraepithelium in mice with obstructive jaundice. World J Surg, 2004,28(3):277–282

    Article  Google Scholar 

  3. Abraham S, Hermesz E, Szabo A, et al. Effects of Kupffer cell blockade on the hepatic expression of metallothionein and heme oxygenase genes in endotoxemic rats with obstructive jaundice. Life Sci, 2012,90(3–4):140–146

    Article  CAS  Google Scholar 

  4. Brandoni A, Di Giusto G, Franca R, et al. Expression of kidney and liver bilitranslocase in response to acute biliary obstruction. Nephron Physiol, 2010,114(4):p35–40

    Article  Google Scholar 

  5. Penkov N. Pathogenetic mechanisms in biliary obstruction (literature review). Khirurgiia (Sofiia), 2003,59(1–2):39–45

    CAS  Google Scholar 

  6. Sepehri Z, Kiani Z, Kohan F, et al. Toll like receptor 4 and hepatocellular carcinoma; A systematic review. Life Sci, 2017,179:80–87

    Article  CAS  Google Scholar 

  7. Zare-Bidaki M, Tsukiyama-Kohara K, Arababadi MK. Toll-like receptor 4 and hepatitis B infection: molecular mechanisms and pathogenesis. Viral Immunol, 2014, 27(7):321–326

    Article  CAS  Google Scholar 

  8. Guo J, Friedman SL. Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis. Fibrogenesis Tissue Repair, 2010,3:21

    Article  Google Scholar 

  9. Pradere JP, Troeger JS, Dapito DH, et al. Toll-like receptor 4 and hepatic fibrogenesis. Semin Liver Dis, 2010,30(3):232–244

    Article  CAS  Google Scholar 

  10. Tang SF, Zhao LJ. Action and mechanism of LPS/TLR4 signaling pathway in hepatolithiasis: recent progress. Chin J Gener Surg (Chinese), 2017,26(2):235–240

    Google Scholar 

  11. Nabih ES, El-Kharashi OA. Targeting HMGB1/TLR4 axis and miR-21 by rosuvastatin: role in alleviating cholestatic liver injury in a rat model of bile duct ligation. Naunyn Schmiedebergs Arch Pharmacol, 2019, 392(1):37–43

    Article  CAS  Google Scholar 

  12. Zhao DY, Han LS, He ZJ, et al. Identification of the Plasma Metabolomics as Early Diagnostic Markers between Biliary Atresia and Neonatal Hepatitis Syndrome. PLoS One, 2014,9(1):e85694

    Article  Google Scholar 

  13. Zhou K, Wang J, Xie G, et al. Distinct Plasma Bile Acid Profiles of Biliary Atresia and Neonatal Hepatitis Syndrome. J Proteome Res, 2015,14(11):4844–4850

    Article  CAS  Google Scholar 

  14. Zhou K, Xie G, Wen J, et al. Histamine is correlated with liver fibrosis in biliary atresia. Dig Liver Dis, 2016,48(8):921–926

    Article  CAS  Google Scholar 

  15. Lee P, Park HJ, Cho N, et al. 3,5-Diethoxy-3′-Hydroxyresveratrol (DEHR) Ameliorates Liver Fibrosis via Caveolin-1 Activation in Hepatic Stellate Cells and in a Mouse Model of Bile Duct Ligation Injury. Molecules, 2018,23(11):2833

    Article  Google Scholar 

  16. Xie B, Liu A, Zhan X, et al. Alteration of gut bacteria and metabolomes after glucaro-1,4-lactone treatment contributes to the prevention of hypercholesterolemia. J Agric Food Chem, 2014,62(30):7444–7451

    Article  CAS  Google Scholar 

  17. Mickiewicz B, Vogel HJ, Wong HR, et al. Metabolomics as a novel approach for early diagnosis of pediatric septic shock and its mortality. Am J Respir Crit Care Med, 2013,187(9):967–976

    Article  CAS  Google Scholar 

  18. Amathieu R, Triba MN, Nahon P, et al. Serum 1H-NMR metabolomic fingerprints of acute-on-chronic liver failure in intensive care unit patients with alcoholic cirrhosis. PLoS One, 2014,9(2):e89230

    Article  Google Scholar 

  19. Yu MJ, Xiang TX, Wu XP, et al. Diagnosis of acute pediatric appendicitis from children with inflammatory diseases by combination of metabolic markers and inflammatory response variables. Clin Chem Lab Med, 2018,56(6):1001–1010

    Article  CAS  Google Scholar 

  20. Yin PY, Wan DF, Zhao CX, et al. A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry. Mol Biosyst, 2009,5(8):868–876

    Article  CAS  Google Scholar 

  21. Zheng P, Gao HC, Li Q, et al. Plasma Metabonomics as a Novel Diagnostic Approach for Major Depressive Disorder. J Prot Res, 2012,11(3):1741–1748

    Article  CAS  Google Scholar 

  22. Mamtimin B, Xia G, Mijit M, et al. Metabolic differentiation and classification of abnormal Savda Munziq’s pharmacodynamic role on rat models with different diseases by nuclear magnetic resonance-based metabonomics. Pharmacogn Mag, 2015,11(44):698–706

    Article  CAS  Google Scholar 

  23. Li M, Yin L, Liu P, et al. LPS increases the liver injury viaTLR4 dependent manner in mice with acute obstructive jaundice. J Hepatobiliary Surg, 2010,18(3):224–227

    Google Scholar 

  24. Zhu J, Lu T, Chen F, et al. Choline Protects Against Intestinal Failure-Associated Liver Disease in Parenteral Nutrition-Fed Immature Rats. JPEN J Parenter Enteral Nutr, 2016:148607116677048

  25. Yamamoto H, Kanno K, Ikuta T, et al. Enhancing hepatic fibrosis in spontaneously hypertensive rats fed a choline-deficient diet: a follow-up report on long-term effects of oxidative stress in non-alcoholic fatty liver disease. J Hepatobiliary Pancreat Sci, 2016,23(5):260–269

    Article  Google Scholar 

  26. Sherriff JL, O’Sullivan TA, Properzi C, et al. Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial Genes. Adv Nutr, 2016,7(1):5–13

    Article  CAS  Google Scholar 

  27. Mikami D, Kobayashi M, Uwada J, et al. β-Hydroxy-butyrate, a ketone body, reduces the cytotoxic effect of cisplatin via activation of HDAC5 in human renal cortical epithelial cells. Life Sci, 2019,222:125–132

    Article  CAS  Google Scholar 

  28. Du X, Liu G, Loor JJ, et al. Impaired hepatic autophagic activity in dairy cows with severe fatty liver is associated with inflammation and reduced liver function. J Dairy Sci, 2018,101(12):11 175–11 185

    Article  CAS  Google Scholar 

  29. Chang Z, Wang H, Li B, et al. Metabolic Characterization of Peripheral Host Responses to Drainage-Resistant Klebsiella pneumoniae Liver Abscesses by Serum 1H-NMR Spectroscopy. Front Cell Infect Microbiol, 2018,8:174

    Article  CAS  Google Scholar 

  30. Lamontagne RJ, Casciano JC, Bouchard MJ. A broad investigation of the HBV-mediated changes to primary hepatocyte physiology reveals HBV significantly alters metabolic pathways. Metabolism, 2018,83:50–59

    Article  CAS  Google Scholar 

  31. Yang W, Zhou G, Zou S, et al. Metabonomics of d-glucaro-1,4-lactone in preventing diethylnitrosamine-induced liver cancer in rats. Pharm Biol, 2018,56(1):643–648

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yong Chai.

Ethics declarations

The authors declare that there is no conflict of interest with any financial organization or corporation or individual that can inappropriately influence this work.

Additional information

This study was supported by the National Natural Science Foundation of China (Nos. 81960101; 81860483).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, Sh., Yu, Mj., Yan, Jl. et al. TLR4 Knockout Attenuates BDL-induced Liver Cholestatic Injury through Amino Acid and Choline Metabolic Pathways. CURR MED SCI 41, 572–580 (2021). https://doi.org/10.1007/s11596-021-2364-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-021-2364-8

Key words

Navigation